Sera Prognostics, Inc. (NasdaqGM: SERA)
Health Care · Biotechnology · US
$2.06
+0.74% today · -33.6% 1Y
Sera Prognostics, Inc. (NasdaqGM: SERA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $80.48M and employs 72 people.
Over the last twelve months the share price has lost 33.6%, trading between 1.56 and 3.95.
Tweenvest scores Sera Prognostics, Inc. across four factors: quality 48/100, value 43/100. Its strongest factor is quality.
SERA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $80.48M
- Revenue (TTM)
- $70.00K
- P/E
- —
- EPS
- -0.66
- Dividend yield
- —
- Beta (5Y)
- 1.06
- 52-week high
- $3.95
- 52-week low
- $1.56
- Avg volume (3M)
- —
- Shares outstanding
- 39.45M
- Employees
- 72
- Next earnings
- —
About Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
- ISIN
- US81749D1072
- Founded
- 2008
- Listed since
- Jul 15, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| 3D Global Biotech Inc.TPEX: 6808 | $83.18M | NT$34.55 | +1.62% |
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $81.85M | $1.75 | -8.38% |
| Prestige Biologics Co., Ltd.KOSDAQ: A334970 | $81.43M | ₩1,408.00 | -1.81% |
| BIONET Therapeutics Corp.TPEX: 7808 | $81.00M | NT$37.00 | -8.64% |
| Greenland Mines LtdNasdaqCM: GRML | $80.35M | $5.50 | -8.72% |
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
| Nordicus Partners CorporationOTCPK: NORD | $79.33M | $4.08 | +1.77% |
Figures last refreshed Oct 11, 2026.